Interestingly, our results showed that in PAAD, RORC expression was negatively correlated with PD-L1, suggesting that high RORC expression may be a reason for the insensitivity to anti-PD-L1 treatment in PAAD. The gene discussed is RORC; the disease is pancreatic adenocarcinoma.